TSCAN THERAPEUTICS
Dead / Abandoned — Abandoned — failure to respond (as of 16 Dec 2022)
What this means for you
This application is over — abandoned 01 Dec 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88124705
- Mark type
- Design + words
- Filed
- 20 Sept 2018
- Published for opposition
- 05 Mar 2019
- Abandoned
- 01 Dec 2022
- Attorney of record
- Joshua Jarvis, Esq.
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development
Owner
- TScan Therapeutics, Inc., Waltham, MA, US
- TScan Therapeutics, Inc., Boston, MA, US
Prosecution history
- 16 Dec 2022 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 16 Dec 2022 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 16 Dec 2022 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 15 Dec 2022 — ASSIGNED TO EXAMINER
- 31 May 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 May 2022 — NON-FINAL ACTION E-MAILED
- 31 May 2022 — SU - NON-FINAL ACTION - WRITTEN
- 18 Apr 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Apr 2022 — USE AMENDMENT FILED
- 15 Apr 2022 — TEAS STATEMENT OF USE RECEIVED
- 31 Aug 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Aug 2021 — SOU EXTENSION 5 GRANTED
- 25 Aug 2021 — SOU EXTENSION 5 FILED
- 30 Aug 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 Aug 2021 — SOU TEAS EXTENSION RECEIVED